[HTML][HTML] Parkinson disease-associated cognitive impairment

D Aarsland, L Batzu, GM Halliday… - Nature Reviews …, 2021 - nature.com
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

JA Obeso, M Stamelou, CG Goetz, W Poewe… - Movement …, 2017 - Wiley Online Library
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a
relevant history of Dr. James Parkinson's himself and what he described accurately and …

The cerebellum in Parkinson's disease

T Wu, M Hallett - Brain, 2013 - academic.oup.com
Parkinson's disease is a chronic progressive neurodegenerative disorder characterized by
resting tremor, slowness of movements, rigidity, gait disturbance and postural instability …

Anticholinergic drugs and risk of dementia: case-control study

K Richardson, C Fox, I Maidment, N Steel, YK Loke… - bmj, 2018 - bmj.com
Objectives To estimate the association between the duration and level of exposure to
different classes of anticholinergic drugs and subsequent incident dementia. Design Case …

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD‐MCI

I Litvan, D Aarsland, CH Adler, JG Goldman… - Movement …, 2011 - Wiley Online Library
There is controversy regarding the definition and characteristics of mild cognitive impairment
in Parkinson's disease. The Movement Disorder Society commissioned a Task Force to …

Parkinson's disease: clinical features and diagnosis

J Jankovic - Journal of neurology, neurosurgery & psychiatry, 2008 - jnnp.bmj.com
Objective: Parkinson's disease (PD) is a progressive neurological disorder characterised by
a large number of motor and non-motor features that can impact on function to a variable …

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

P Svenningsson, E Westman, C Ballard… - The Lancet …, 2012 - thelancet.com
Dementia is one of the most common and important aspects of Parkinson's disease and has
consequences for patients and caregivers, and has health-related costs. Mild cognitive …

Cognition deficits in Parkinson's disease: mechanisms and treatment

C Fang, L Lv, S Mao, H Dong, B Liu - Parkinson's disease, 2020 - Wiley Online Library
Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder mainly in middle‐elderly population, which represents diverse nonmotor symptoms …

Clinical diagnostic criteria for dementia associated with Parkinson's disease

M Emre, D Aarsland, R Brown, DJ Burn… - … : official journal of the …, 2007 - Wiley Online Library
Dementia has been increasingly more recognized to be a common feature in patients with
Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of …

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

CH Williams-Gray, JR Evans, A Goris, T Foltynie… - Brain, 2009 - academic.oup.com
Cognitive abnormalities are common in Parkinson's disease, with important social and
economic implications. Factors influencing their evolution remain unclear but are crucial to …